Trials sponsored by academic investigators, cooperative groups more likely to use these criteria
Dose-response effect observed in overweight African-Americans with vitamin D deficiency
Continuous drop in combined cancer death rate from 1991 to 2015, resulting in 2,378,600 fewer death.
New findings suggest that national strategies have failed to correct racial/ethnic disparities in live donor kidney transplantation.
African-Americans less likely to be wait-listed; higher income positively associated with wait-listing.
Each 1 standard deviation in baseline uric acid levels was associated with a significant 80% increased odds of rapid kidney function decline.
The researchers found that scores on the cognitive tests were linked with the patient's systolic blood pressure.
Study of men with intermediate- or high-risk prostate cancer finds facility-level racial disparity in use of definitive treatment.
Across time, only African-American race correlated with greater regret.
Between 2002 and 2013, heart failure hospitalizations declined by 30.8% nationwide, and continue to drop.
No added benefit was seen with the addition of biomarkers for African-American men.
What's important is that doctors and other health-care providers, as well as patients, don't just assume these differences are normal and inconsequential.
The researchers observed a narrowing of disparities in the average monthly transplantation rates with implementation of the new system.
The researchers found that black race and male sex correlated with increased risk of ESRD in donors.
The US Preventive Services Task Force now suggests decisions about PSA testing should be made on an individual basis for men aged 55 to 69.
Highest vs lowest quartile of vitamin D binding protein associated with 55% lower odds of prostate cancer.
The USPSTF guidelines focus statin recommendations on 38% of high-risk African American individuals at the expense of not recommending treatment in nearly 25% of African Americans.
Carriers have a 2-fold higher risk of end-stage renal disease compared with non-carriers, study finds.
Study finds that PSA and PSAD indicated prostate cancer above Gleason score 6 for white men only.
Black patients who met age criteria for PSA screening were 28% more likely to die of their prostate cancer than patients ineligible for screening.
Blacks had significantly higher median baseline serum urate levels compared to whites.
The median OS differed by race, with superior OS observed among Asian men than among men of other races.
Non-Hispanic black children had a 36% higher risk of death and Hispanic children had a 34% lower risk of death than non-Hispanic white children.
Blacks have increased incidence of hypertension, diabetes mellitus, dyslipidemia, but not a-fib.
Within each D'Amico risk category, African-American and Hispanic prostate cancer patients were less likely to receive definitive treatment than white patients.
Greatest racial disparity found in Los Angeles, the least in Minneapolis.
Even black men with relatively few comorbidities had increased risks of upgrading or upstaging compared with non-black patients.
Black CKD patients with strict blood pressure control had a 19% lower risk of premature death.
Androgen deprivation increased all-cause mortality risk by 77% among black men who underwent brachytherapy for favorable-risk prostate cancer.
Blacks found to be slightly more likely than whites to leave observational management to undergo radiotherapy or surgery.
Renal and Urology News Articles
Sign Up for Free e-newsletters
NEPHROLOGY & UROLOGY NEWS
- Acute Kidney Injury (AKI)
- Chronic Kidney Disease (CKD)
- Contrast Nephropathy
- Cardiovascular Disease (CVD)
- Diabetic Nephropathy
- End-stage Renal Disease (ESRD)
- Lupus Nephritis
- Peritoneal Dialysis
- Secondary Hyperparathyroidism (SHPT)